波兰孕期糖尿病的季节性模式:一个回顾性队列研究
Marek J Walkowiak1, Małgorzata Jamka2, Marcin Piotr Walkowiak3
1Department of Reproduction, Poznan University of Medical Sciences, Polna Str. 33, 60-535 Poznan, Poland.
Biology
|November 24, 2023
概括
波兰孕期糖尿病 (GDM) 风险呈现季节性变化,春季流行率较低. 这一发现强调了在GDM风险评估中考虑季节性因素的重要性.
科学领域:
- 生殖医学 生殖医学
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 现有的文献缺乏关于中东欧孕期季节性影响的数据.
- 孕期糖尿病 (GDM) 是一个重要的妊娠并发症,具有潜在的环境联系.
研究的目的:
- 调查波兰人口中妊娠糖尿病 (GDM) 患病率的季节性变化.
- 确定季节性模式是否与孕妇GDM风险有关.
主要方法:
- 对波兰30205例单独怀孕的数据进行了回顾性分析.
- 包括变量:出生日期,妊娠年龄,新生儿特征,母因子,并发症 (包括GDM) 和分娩方式.
主要成果:
- 与其他季节 (16.78%) 相比,春季GDM患病率显著下降 (14.71%).
- 在夏季 (六月至八月) 与冬季 (十二月至二月) 测试的母亲中观察到更高的GDM发病率 (17.34%对14.75%).
- 季节性模式,包括阳光照射水平,与GDM患病率有显著的关联.
结论:
- 这项大型队列研究表明,GDM风险的季节性变化很大.
- 在GDM流行中观察到的季节性模式适用于按期和早产.
- 建议进行进一步的研究,以探索GDM风险,季节性影响和潜在的性别关联.
相关概念视频
Pathophysiology of Diabetes
950
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
950
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Diabetes: Symptoms, Diagnosis, and Complications
554
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
554
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Glucose Transporters
22.8K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.8K
Oral Hypoglycemic Agents: Biguanides and Glitazones
210
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
210


